NeuroPace Inc
NPCE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001528287
No open-market purchases or sales by NeuroPace Inc insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $422.4M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding NeuroPace Inc changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 41 | 40 | −1 |
| Shares | 18.0M | 18.2M | +198.7K (+1.1%) |
| Value | $181.5M | $149.5M | −$32.0M (−17.6%) |
New holders (5)
Institutions that held NeuroPace Inc at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Barclays PLC | 4,553 | $38.0K | 0.00% |
| Amalgamated Bank | 1,156 | $9.00K | 0.00% |
| Amalgamated Financial Corp. | 1,156 | $9.00K | 0.00% |
| Capital Advisors, Ltd. LLC | 41 | $0 | 0.00% |
| Cubist Systematic Strategies, LLC | 18 | $0 | 0.00% |
Sold out (6)
Institutions that held NeuroPace Inc at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Pictet Asset Management SA | 560,444 | $5.65M |
| Lord, Abbett & Co. LLC | 355,972 | $3.59M |
| Qube Research & Technologies Ltd | 19,086 | $192.0K |
| Citadel Advisors LLC | 10,009 | $101.0K |
| Point72 Hong Kong Ltd | 291 | $3.00K |
| Advisor Group Holdings, Inc. | 145 | $1.00K |